The John Radcliffe Hospital

Oxford OX3 9DU

4 studies enrolling now · 5 studies all time

What they study most

Atherosclerosis, Cardiovascular Diseases, Crohn's Disease, Diabetes Mellitus, Type 1, Inflammatory Bowel Diseases, Lipoprotein(a), Metabolic Dysfunction-Associated Steatotic Liver Disease, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — Recruiting now
• A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling